Degree of Lung Maturity Determines the Direction of the Interleukin-1–Induced Effect on the Expression of Surfactant Proteins
Authors:
- 1 March 2000
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 22 (3) , 280-288
Abstract
Intra-amniotic interleukin (IL)-1 increases surfactant components in immature fetal lung, whereas high IL-1 after birth is associated with surfactant dysfunction. Our aim was to investigate whether the fetal age influences the responsiveness of surfactant proteins (SPs) to IL-1. Rabbit lung explants from fetuses at 19, 22, 27, and 30 d of gestation and 1-d-old newborns were cultured in serum-free medium in the presence of recombinant human (rh) IL-1α or vehicle. The influence of IL-1α on SP-A, -B, and -C messenger RNA (mRNA) content was dependent on the conceptional age. In very immature lung on Day 19, rhIL-1α (570 ng/ml for 20 h) increased SP-A, -B, and -C mRNA by 860 ± 15%, 314 ± 108%, and 64 ± 17%, respectively. The increase in SP-A mRNA was evident within 4 to 6 h. IL-1α increased the SP-A concentration in alveolar epithelial cells and in the culture medium within 20 h. In contrast, at 27 to 30 d of gestation and in newborns, IL-1α decreased SP-C, -B, and -A mRNA by means of 64 to 67%, 48 to 59%, and 12 to 15%, respectively. SP-B protein decreased by 45 to 60%. The decrease in mRNA became evident within 8 to 12 h and was dependent on IL-1 concentration. On Day 27, IL-1α accelerated the degradation of SP-B mRNA in the presence of actinomycin D. IL-1 did not increase the degradation rate of SP-A mRNA unless both actinomycin D and cycloheximide were added to the explants. The present findings may explain some of the contrasting associations between inflammatory cytokines and lung diseases during the perinatal period. The determinants of the direction of the IL-1 effect on the expression of SPs remain to be identified.Keywords
This publication has 36 references indexed in Scilit:
- Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor AntagonistInternational Reviews of Immunology, 1998
- Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth.Journal of Clinical Investigation, 1997
- AP-1 function and regulationCurrent Opinion in Cell Biology, 1997
- Intra-Amniotic Interleukin-1α Treatment Alters Postnatal Adaptation in Premature LambsNeonatology, 1997
- Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)Growth Factors, 1993
- Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.Journal of Clinical Investigation, 1991
- Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein.Journal of Clinical Investigation, 1990
- Pulmonary surfactant and its apoproteins.Journal of Clinical Investigation, 1990
- Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.Journal of Clinical Investigation, 1982
- The in vivo labeling with acetate and palmitate of lung phospholipids from developing and adult rabbitsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980